Who
Ping Zhang
Director
Company insider
Files Form 4 as: Director, Gyre Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 5 Jan 2025
- Last trade
- 10 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 30 Jun 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 10 Jun 2026filed 30 Jun 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 14 May 2026filed 20 May 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —250,000 at $0.00 | filing |
| 14 May 2026filed 20 May 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —250,000 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 7 Jan 2026filed 9 Jan 2026 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 5 Aug 2025filed 7 Aug 2025 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 27 May 2025filed 28 May 2025 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 5 Jan 2025filed 7 Jan 2025 | GYRE Gyre Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.